Curaleaf Hldgs Stock Price, News & Analysis

Curaleaf announced the launch of its Select Fresh line of cannabis oils, featuring bold fruit flavors and a new .3 gram 'Go' cartridge. This innovative product will be available simultaneously in 10 states, expanding the brand's reach and commitment to consistency across the U.S. market. Select Fresh aims to cater to consumers seeking flavorful vaping experiences at an attractive price point, aligning with Curaleaf's strategy to enhance its product portfolio. The rollout in states like Arizona, Connecticut, and California supports Curaleaf's position as a leading cannabis provider.

Curaleaf Holdings has appointed Carlos Madrazo as the Senior Vice President of Investor Relations and Capital Markets, a newly created position, effective March 15, 2021. Madrazo, who brings over 20 years of international experience in investor relations and investment banking, will work with the Executive Leadership Team to enhance shareholder knowledge, corporate finance strategies, and communication. His appointment coincides with Curaleaf's expansion into the international cannabis market, particularly following the acquisition of EMMAC Life Sciences, the largest independent cannabis company in Europe.

Planet 13 Holdings (OTCQB: PLNHF) has partnered with Curaleaf's Select brand to launch a unique shop-in-shop at its Las Vegas SuperStore, which opened on March 15, 2021. This collaboration aims to highlight Select's extensive product line, providing an educational and sales platform for the brand's offerings, including Select Elite and Nano Gummies. As Select is recognized as America’s top cannabis oil brand, the partnership is expected to boost Planet 13's visibility and appeal in the cannabis market, especially among tourists visiting Las Vegas.

Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) announced that CEO Joseph Bayern will participate in the Cannabis State of the Industry Panel at the Roth Capital Partners Virtual 33rd Annual Conference on March 16, 2021, at 2:00 pm ET. Investors can access the webcast through Curaleaf's investor relations website. Curaleaf is a leading cannabis consumer product provider in the U.S., operating 101 dispensaries, 23 cultivation sites, and employing over 3,800 team members across 23 states.

Curaleaf Holdings reported record financial results for Q4 and FY2020. Managed revenue reached $233.3 million in Q4, reflecting a 186% year-over-year increase, while total revenue was $230.3 million, up 205% from the prior year. For FY2020, managed revenue was $653.0 million, a 161% growth, with total revenue at $626.6 million, up 184%. Adjusted EBITDA for Q4 reached $53.8 million, a 289% increase. Despite these gains, the company reported a net loss of $35.3 million for Q4.

Curaleaf aims to expand further with its entry into the European market.

Curaleaf announced a definitive agreement to acquire EMMAC Life Sciences for approximately US$286 million, consisting of 85% Curaleaf shares and 15% cash. This acquisition provides Curaleaf with a strategic entry into the European cannabis market, leveraging EMMAC's established operations across key countries like the UK, Germany, and Portugal. The deal includes contingent consideration of up to US$57 million based on performance milestones. Curaleaf aims to expand its brand presence in Europe, anticipating the market could exceed US$120 billion in the future.

Curaleaf Holdings has announced the expansion of its Select brand products into Utah, making it available across 17 states. Starting with the Select Elite cartridges, these products aim to enhance patient access to high-quality medical cannabis. The initial rollout is set to begin at the Curaleaf pharmacy in Lehi, UT. Select continues to meet high-quality standards and aims to educate consumers. The company's extensive operational footprint includes 101 dispensaries and serves over 18,400 active patient cardholders in Utah.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has announced that it will report its financial results for Q4 and the fiscal year ending December 31, 2020, on March 9, 2021. The company will host a conference call at 4:30 p.m. ET for a discussion on operational and financial highlights. Curaleaf operates in 23 states with 101 dispensaries and a workforce of over 3,800 employees. The results are anticipated to provide investors with insights into the company’s performance in the growing cannabis market.